Literature DB >> 33185181

SARS-CoV-2 Seropositivity in Asymptomatic Frontline Health Workers in Ibadan, Nigeria.

Olatunde Olayanju1,2, Olabisi Bamidele1, Fabian Edem3, Bola Eseile1, Abimbola Amoo4, Jude Nwaokenye4, Chioma Udeh1, Gabriel Oluwole5, Gabriel Odok1, Nnaemeka Awah1.   

Abstract

Global health has been thrown into turmoil by the COVID-19 pandemic, which has caused devastating morbidity and unprecedented loss of life in almost all continents of the world. It was predicted that the magnitude of the pandemic in Africa will be high because of poor health structure and intensely poor living condition, but that has not happened, surprisingly. It was hypothesized that the youthful population and a vastly primed immune system were protective, and many people may have been exposed without coming down with the severe disease. Most of them would have presented in hospitals with other medical conditions and possibly transmit COVID-19 to health workers inadvertently. This study is designed to measure serum SARS-CoV-2 IgG levels in health workers as a marker of latent exposure. Asymptomatic frontline health workers were randomly selected from the University College Hospital Ibadan, Nigeria; venous blood samples were obtained from them, and the serum SARS-CoV-2 IgG level was determined using ELISA techniques. A proportion of participants with seropositivity were obtained, and factors associated with seropositivity were determined. A total of 133 participants were recruited for this study. And, 60 (45.1%) of them were seropositive for SARS-CoV-2. Among the seropositive participants were doctors, nurses, health assistants, laboratory scientists and technicians, and nonmedical staff. Obstetrics, gynecology, and emergency departments had higher odds of seropositivity. Seroprevalence of SARS-CoV-2 is very high among frontline health workers, though asymptomatic. This calls for a more stringent precaution against further spread within the hospital environment.

Entities:  

Year:  2020        PMID: 33185181     DOI: 10.4269/ajtmh.20-1235

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  27 in total

1.  Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis.

Authors:  Khalid Hajissa; Md Asiful Islam; Siti Asma Hassan; Abdul Rahman Zaidah; Nabilah Ismail; Zeehaida Mohamed
Journal:  Int J Environ Res Public Health       Date:  2022-06-14       Impact factor: 4.614

2.  SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020-2021.

Authors:  Dagmar Alber; Fadima Cheick Haidara; Juho Luoma; Laura Adubra; Per Ashorn; Ulla Ashorn; Henry Badji; Elaine Cloutman-Green; Fatoumata Diallo; Rikhard Ihamuotila; Nigel Klein; Owen Martell; Uma U Onwuchekwa; Oumar Samaké; Samba O Sow; Awa Traore; Kevin Wilson; Camilla Ducker; Yue-Mei Fan
Journal:  BMJ Open       Date:  2022-06-16       Impact factor: 3.006

3.  'Why Should I Take the COVID-19 Vaccine after Recovering from the Disease?' A Mixed-methods Study of Correlates of COVID-19 Vaccine Acceptability among Health Workers in Northern Nigeria.

Authors:  Zubairu Iliyasu; Muhammad R Garba; Auwalu U Gajida; Taiwo G Amole; Amina A Umar; Hadiza M Abdullahi; Aminatu A Kwaku; Hamisu M Salihu; Muktar H Aliyu
Journal:  Pathog Glob Health       Date:  2021-12-22       Impact factor: 3.735

4.  Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201.

Authors:  Kirsten E Wiens; Pinyi Nyimol Mawien; John Rumunu; Damien Slater; Forrest K Jones; Serina Moheed; Andrea Caflisch; Bior K Bior; Iboyi Amanya Jacob; Richard Lino Lako; Argata Guracha Guyo; Olushayo Oluseun Olu; Sylvester Maleghemi; Andrew Baguma; Juma John Hassen; Sheila K Baya; Lul Deng; Justin Lessler; Maya N Demby; Vanessa Sanchez; Rachel Mills; Clare Fraser; Richelle C Charles; Jason B Harris; Andrew S Azman; Joseph F Wamala
Journal:  Emerg Infect Dis       Date:  2021-06       Impact factor: 6.883

5.  Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.

Authors:  Sarah Lapidus; Feimei Liu; Arnau Casanovas-Massana; Yile Dai; John D Huck; Carolina Lucas; Jon Klein; Renata B Filler; Madison S Strine; Mouhamad Sy; Awa B Deme; Aida S Badiane; Baba Dieye; Ibrahima Mbaye Ndiaye; Younous Diedhiou; Amadou Moctar Mbaye; Cheikh Tidiane Diagne; Inés Vigan-Womas; Alassane Mbengue; Bacary D Sadio; Moussa M Diagne; Adam J Moore; Khadidiatou Mangou; Fatoumata Diallo; Seynabou D Sene; Mariama N Pouye; Rokhaya Faye; Babacar Diouf; Nivison Nery; Federico Costa; Mitermayer Reis; M Catherine Muenker; Daniel Z Hodson; Yannick Mbarga; Ben Z Katz; Jason R Andrews; Melissa Campbell; Ariktha Srivathsan; Kathy Kamath; Elisabeth Baum-Jones; Ousmane Faye; Amadou Alpha Sall; Juan Carlos Quintero Vélez; Michael Cappello; Michael Wilson; Choukri Ben-Mamoun; Fabrice A Somé; Roch K Dabiré; Carole Else Eboumbou Moukoko; Jean Bosco Ouédraogo; Yap Boum; John Shon; Daouda Ndiaye; Adam Wisnewski; Sunil Parikh; Akiko Iwasaki; Craig B Wilen; Albert I Ko; Aaron M Ring; Amy K Bei
Journal:  medRxiv       Date:  2021-05-12

6.  Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.

Authors:  Anthony O Etyang; Ruth Lucinde; Henry Karanja; Catherine Kalu; Daisy Mugo; James Nyagwange; John Gitonga; James Tuju; Perpetual Wanjiku; Angela Karani; Shadrack Mutua; Hosea Maroko; Eddy Nzomo; Eric Maitha; Evanson Kamuri; Thuranira Kaugiria; Justus Weru; Lucy B Ochola; Nelson Kilimo; Sande Charo; Namdala Emukule; Wycliffe Moracha; David Mukabi; Rosemary Okuku; Monicah Ogutu; Barrack Angujo; Mark Otiende; Christian Bottomley; Edward Otieno; Leonard Ndwiga; Amek Nyaguara; Shirine Voller; Charles N Agoti; David James Nokes; Lynette Isabella Ochola-Oyier; Rashid Aman; Patrick Amoth; Mercy Mwangangi; Kadondi Kasera; Wangari Ng'ang'a; Ifedayo M O Adetifa; E Wangeci Kagucia; Katherine Gallagher; Sophie Uyoga; Benjamin Tsofa; Edwine Barasa; Philip Bejon; J Anthony G Scott; Ambrose Agweyu; George M Warimwe
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

7.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Juba, South Sudan: a population-based study.

Authors:  Kirsten E Wiens; Pinyi Nyimol Mawien; John Rumunu; Damien Slater; Forrest K Jones; Serina Moheed; Andrea Caflish; Bior K Bior; Iboyi Amanya Jacob; Richard Lino Loro Lako; Argata Guracha Guyo; Olushayo Oluseun Olu; Sylvester Maleghemi; Andrew Baguma; Juma John Hassen; Sheila K Baya; Lul Deng; Justin Lessler; Maya N Demby; Vanessa Sanchez; Rachel Mills; Clare Fraser; Richelle C Charles; Jason B Harris; Andrew S Azman; Joseph F Wamala
Journal:  medRxiv       Date:  2021-03-12

8.  Seroprevalence of hospital staff in a province with zero COVID-19 cases.

Authors:  Tanawin Nopsopon; Krit Pongpirul; Korn Chotirosniramit; Wutichai Jakaew; Chuenkhwan Kaewwijit; Sawan Kanchana; Narin Hiransuthikul
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

9.  Population seroprevalence of SARS-CoV-2 antibodies in Anambra state, South-East, Nigeria.

Authors:  OgoChukwu Vincent Okpala; Cyril Chukwudi Dim; Chukwuebuka Immanuel Ugwu; Simeon Onyemaechi; Obiageli Uchebo; Ugochukwu Chukwulobelu; Chuma Emembolu; Ben Okoye; Chukwumuanya Igboekwu; Uchenna Benedict Okoye; Nelly Chibuzor Dike; Anastasia Obiageli Odumegwu; Christopher Ideh; Ngozi Christiana Okoye; Vincent Chinedu Okpala; Peter Ikenna Okoye; Maryann Chinyere Enike; Oluchi Onyedikachi
Journal:  Int J Infect Dis       Date:  2021-07-19       Impact factor: 3.623

10.  SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey.

Authors:  Mohamed Bailor Barrie; Sulaiman Lakoh; J Daniel Kelly; Joseph Sam Kanu; James Squire; Zikan Koroma; Silleh Bah; Osman Sankoh; Abdulai Brima; Rashid Ansumana; Sarah A Goldberg; Smit Chitre; Chidinma Osuagwu; Justin Maeda; Bernard Barekye; Tamuno-Wari Numbere; Mohammed Abdulaziz; Anthony Mounts; Curtis Blanton; Tushar Singh; Mohamed Samai; Mohamed A Vandi; Eugene T Richardson
Journal:  medRxiv       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.